SF3B1 and breast neoplasm: SF3B1 mutations in the K700 and K666 residues have been reported also in breast tumors [21,48] and in pancreatic ductal adenocarcinomas [49], whereas mutations of residues R625 and K666 were found in uveal melanomas [24,50,51] and cutaneous melanomas [52,53].